https://tofacitinibinhibitor.c....om/naoxintong-restor
By end regarding the observance duration, both teams presented similar BCVA (group 1 67.4 ± 19.3, group 2 66.8 ± 17.2 letters; p = 0.51), visual gains (group 1 7.8 ± 16.9, team 2 5.8 ± 14.4 letters; p = 0.11), CRT values (group 1 259.6 ± 80.5, group 2 277.4 ± 87.1 μm; p = 0.1, and wide range of treatments (group 1 13.0 ± 4.5, team 2 11.6 ± 4.1 injections; p = 0.09), as well as percentage of eyes with stable illness (lack of any intraretinal fluid and lac
Like
Comment
Share
